NASDAQ OMX Helsinki Oy

  • ISIN: SE0001322157
  • Land: .

Nachricht vom 16.03.2012 | 15:30

NASDAQ OMX Vilnius investor calendar week 12/2012


NASDAQ OMX Vilnius 

16.03.2012 15:30

Primary placement auction of Lithuanian Government securities 19-03-2012 - Lithuanian Government Bonds (ISIN code: LT0000607053) More information: https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=494 779&messageId=606379 Start of mandatory tender offer to buy shares 21-03-2012 - AB Snaigė (ticker: SNG1LTOE1) Annual audited Consolidated Financial Statements for the year 2011 22-03-2012 - TEO LT, AB (ticker: TEO1L) Extraordinary general meeting of shareholders 23-03-2012 - AB Lietuvos dujos (ticker: LDJ1L) Please note that the existing investor calendar available on NASDAQ OMX Baltic web page has been improved. Now information on all Baltic listed companies is available in one place, also a convenient search function has been added. Even more, it is now possible to add the events you are interested in directly to your electronic calendar. To visit the new investor calendar, please click here: http://www.nasdaqomxbaltic.com/market/?pg=calendar&lang=en NASDAQ OMX Vilnius Market Services Department +370 5 272 36 11 News Source: NASDAQ OMX 16.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: NASDAQ OMX Vilnius Sweden Phone: Fax: E-mail: Internet: ISIN: SE0001322157 WKN: End of Announcement DGAP News-Service

GBC im Fokus

Ergomed PLC: Kursziel angehoben

Die erfolgreiche Wirksamkeitsstudie von Lorediplon zeigt, dass Ergomed PLC eine sehr vielversprechende Co-Development-Pipeline hat. Eine mögliche vorzeitige Auslizenzierungen des Produkts würde dem Unternehmen signifikante Erfolgsbeteiligungen sichern. Deshalb und aufgrund der Anpassung der Wechselkurse erhöhen wir den fairen Wert der Ergomed-Aktie auf 3,41 € je Aktie. Das Rating bleibt KAUFEN.

News im Fokus

Henkel AG & Co. KGaA:

23. Februar 2017, 07:30

Aktueller Webcast

XING AG

Preliminary Results 2016

23. Februar 2017

Aktuelle Research-Studie

Sanochemia Pharmazeutika AG

Original-Research: Sanochemia Pharmazeutika AG (von Sphene Capital GmbH): Buy

23. Februar 2017